WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA

Clinical trials for WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA explained in plain language.

Never miss a new study

Get alerted when new WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA trials appear

Sign up with your email to follow new studies for WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug trial targets rare blood disorder where body attacks its own red cells

Disease control Ongoing

This clinical trial is testing an investigational drug called HMPL-523 for adults with warm antibody autoimmune hemolytic anemia (wAIHA), a condition where the immune system mistakenly destroys red blood cells. The study aims to see if the drug can safely and effectively increase…

Matched conditions: WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA

Phase: PHASE2, PHASE3 • Sponsor: Hutchison Medipharma Limited • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA

Get alerted when new WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA trials appear

New drug trial targets rare blood disorder where body attacks its own red cells